Home
Savara Pharmaceuticals

Savara Pharmaceuticals Market Share Analysis for January 2026

Savara Inc. is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. Learn more.

Health > Biotechnology and Pharmaceuticals

Domainsavarapharma.com

Year Founded2008

Employees51 - 200

Annual Revenue< $1M

Savara Pharmaceuticals

Savara Pharmaceuticals (including company regionals)

savarapharma.com

See more website traffic and engagement information

Total visits to Savara Pharmaceuticals's top domains

Understand Savara Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

savarapharma.com4K

See more with Sales Intelligence

Avg. visit duration in Savara Pharmaceuticals's top domains

Analyze Savara Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

savarapharma.com00:00:48

See more with Sales Intelligence

Avg. pageviews on Savara Pharmaceuticals's top domains

See how Savara Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

savarapharma.com2.05

See more with Sales Intelligence

Savara Pharmaceuticals top competitors by domain

Top similar sites in January 2026, ranked by their affinity

alderbio.comCompany NameAlder BioPharmaceuticals, Inc.Employees201 - 500HQUnited States, Washington, BothellAnnual revenue$5M - $10MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Savara Pharmaceuticals

These are the website technologies, by industry, used by Savara Pharmaceuticals top domains

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

6

See all

News & Signals from Savara Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDavid Ramsay at Savara Inc. receives award 40,000 RSU award.Savara Inc (SVRA) director David Ramsay receives 40,000 RSU award.

NewsSavara Inc. had issues with class action securities lawsuit on Oct 29th '25.NEW YORK, Oct. 29, 2025 /PRNewswire/ - A securities fraud class action lawsuit against Savara Inc. (NASDAQ: SVRA) is pending.

NewsSavara Inc. promotes Yasmine Wasfi to Chief Medical Officer.Savara promotes Dr. Yasmine Wasfi to Chief Medical Officer.